ITCC-032 BEACON
A randomised phase IIb trial of BEvACizumab added to Temozolomide ± IrinOtecan for children with refractory/relapsed Neuroblastoma
Promotor Name : CRCTU
Investigator Name : L. MORENO
Trial is registered on clinicaltrial.gov: NCT02308527